Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORC
5501
Orchid Island Capital
ORC
$1.32B
| $69K | ﹤0.01% |
6,563
+4,413
| +205% | +$45.6K |
|
5502
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$692M
| $69K | ﹤0.01% |
+3,607
| New | +$62.9K |
|
|
VOXX
5503
DELISTED
VOXX International Corporation Class A
VOXX
| $69K | ﹤0.01% |
5,532
-3,307
| -37% | -$39.1K |
|
|
PETQ
5504
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $69K | ﹤0.01% |
4,522
-1,813
| -29% | -$23.3K |
|
5505
iShares MSCI Indonesia ETF
EIDO
$489M
| $68K | ﹤0.01% |
2,936
+377
| +15% | +$8.93K |
|
|
FARO
5506
DELISTED
Faro Technologies
FARO
| $68K | ﹤0.01% |
4,183
+2,959
| +242% | +$52.3K |
|
5507
Park-Ohio Holdings
PKOH
$716M
| $68K | ﹤0.01% |
3,602
-1,606
| -31% | -$24.4K |
|
|
RCS
5508
PIMCO Strategic Income Fund
RCS
$250M
| $68K | ﹤0.01% |
13,005
+2,118
| +19% | +$11.2K |
|
5509
Theravance Biopharma
TBPH
$881M
| $68K | ﹤0.01% |
6,532
+1,649
| +34% | +$18.2K |
|
|
EGRX
5510
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $68K | ﹤0.01% |
3,504
-1,538
| -31% | -$36.5K |
|
|
GRTX
5511
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $68K | ﹤0.01% |
21,943
+12,055
| +122% | +$35.9K |
|
|
BVH
5512
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $68K | ﹤0.01% |
1,921
-1,008
| -34% | -$30.3K |
|
5513
Algoma Steel Group Warrant
ASTLW
$155K
| $67K | ﹤0.01% |
55,400
+10,000
| +22% | +$15.7K |
|
5514
Mission Produce
AVO
$1.15B
| $67K | ﹤0.01% |
5,578
-415
| -7% | -$4.89K |
|
5515
MBIA
MBI
$264M
| $67K | ﹤0.01% |
7,711
+2,423
| +46% | +$21.8K |
|
|
MCI
5516
Barings Corporate Investors
MCI
$350M
| $67K | ﹤0.01% |
4,481
-993
| -18% | -$14K |
|
5517
Riley Exploration Permian
REPX
$800M
| $67K | ﹤0.01% |
1,874
+1,273
| +212% | +$49.7K |
|
|
CBAY
5518
DELISTED
Cymabay Therapeutics
CBAY
| $67K | ﹤0.01% |
6,088
+6,062
| +23,315% | +$56.4K |
|
|
EBIX
5519
DELISTED
Ebix Inc
EBIX
| $67K | ﹤0.01% |
2,659
+1,066
| +67% | +$20K |
|
5520
Alico
ALCO
$297M
| $66K | ﹤0.01% |
2,582
-1,888
| -42% | -$45.9K |
|
5521
Altimmune
ALT
$572M
| $66K | ﹤0.01% |
19,038
+7,347
| +63% | +$33K |
|
5522
Ardmore Shipping
ASC
$719M
| $66K | ﹤0.01% |
5,376
-34,519
| -87% | -$461K |
|
5523
Broadway Financial
BYFC
$111M
| $66K | ﹤0.01% |
8,547
+25
| +0.3% | +$196 |
|
5524
Conduent
CNDT
$236M
| $66K | ﹤0.01% |
19,296
+4,155
| +27% | +$13.6K |
|
5525
Cogent Biosciences
COGT
$6.58B
| $66K | ﹤0.01% |
5,630
+2,027
| +56% | +$23.3K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.